Human perivascular stem cell-based bone graft substitute induces rat spinal fusion

Stem Cells Translational Medicine

Volumn 3, Issue 10, 2014, Pages 1231-1241

  Chung, Choon G ^a   James, Aaron W ^a,b   Asatrian, Greg ^a   Chang, Le ^a   Nguyen, Alan ^a   Le, Khoi ^a   Bayani, Georgina ^a   Lee, Robert ^a   Stoker, David ^c   Zhang, Xinli ^a   Ting, Kang ^a   Péault, Bruno ^a,d   Soo, Chia ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Marina Plastic Surgery Associates   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Adventitial cell; Mesenchymal stem cell; Osteogenesis; Pericyte; Perivascular stem cell; Tissue engineering

Indexed keywords

CD146 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE GRAFT; CELL REGENERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; NONHUMAN; OSSIFICATION; PERICYTE; PERIVASCULAR STEM CELL; RAT; SCORING SYSTEM; SPINE FUSION; STEM CELL; STROMA CELL; STROMAL VASCULAR FRACTION; ANIMAL; BONE DEVELOPMENT; BONE TRANSPLANTATION; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; FINITE ELEMENT ANALYSIS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES; XENOGRAFT;

RATTUS;

ANIMALS; BONE TRANSPLANTATION; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; FINITE ELEMENT ANALYSIS; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; RATS; SPINAL FUSION; X-RAY MICROTOMOGRAPHY;

EID: 84908046585     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0027     Document Type: Article

References (80)

1. Yelin E, Callahan LF. The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum 1995;38: 1351-1362.
2. American Academy of Orthopaedic Surgeons. Burden of Musculoskeletal Diseases in the United States: Prevalence, Societal and Economic Cost. Rosemont, IL: American Academy of Orthopaedic Surgeons, 2008.
3. Deyo RA, Gray DT, KreuterWet al. United States trends in lumbar fusion surgery for degenerativeconditions. Spine2005;30:1441-1445; discussion 1446-1447.
4. Gray DT, Deyo RA, Kreuter W et al. Population-based trends in volumes and rates of ambulatory lumbar spine surgery. Spine 2006;31:1957-1964.
5. Katz JN. Lumbar spinal fusion. Surgical rates, costs, and complications. Spine 1995;20 (suppl):78S-83S.
6. Lee CK, Langrana NA. A review of spinal fusion for degenerative disc disease: Need for alternative treatment approach of disc arthroplasty? Spine J 2004;4(suppl):173S-176S.
7. Taylor VM, Deyo RA, Cherkin DC et al. Low back pain hospitalization. Recent United States trends and regional variations. Spine 1994;19: 1207-1213.
8. Mikhael MM, Huddleston PM, Nassr A. Postoperative culture positive surgical site infections after the use of irradiated allograft, nonirradiated allograft, or autograft for spinal fusion. Spine 2009;34:2466-2468.
9. Sawin PD, Traynelis VC, Menezes AH. A comparative analysis of fusion rates and donor-site morbidity for autogeneic rib and iliac crest bone grafts in posterior cervical fusions. J Neurosurg 1998;88:255-265.
10. Wolfe SA. Complications of harvesting cranial bone grafts. Plast Reconstr Surg 1996; 98:567.
11. Deans RJ, Moseley AB. Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol 2000;28:875-884.
12. Minguell JJ, Conget P, Erices A. Biology and clinical utilization of mesenchymal progenitor cells. Braz J Med Biol Res 2000;33:881-887.
13. Schwartz RE, Reyes M, Koodie L et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocytelike cells. J Clin Invest 2002;109:1291-1302.
14. Moerman EJ, Teng K, Lipschitz DA et al. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: The role of PPARgamma2 transcription factor and TGF-beta/ BMP signaling pathways. Aging Cell 2004;3: 379-389.
15. Giannoudis P, Tzioupis C, Almalki T et al. Fracture healing in osteoporotic fractures: Is it really different? A basic science perspective. Injury 2007;38(suppl 1):S90-S99.
16. McIntosh K, Zvonic S, Garrett S et al. The immunogenicity of human adipose-derived cells: Temporal changes in vitro. STEMCELLS 2006; 24:1246-1253.
17. Meliga E, Strem BM, Duckers HJ et al. Adipose-derived cells. Cell Transplant 2007; 16:963-970.
18. De Ugarte DA, Morizono K, Elbarbary A et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003;174:101-109.
19. Aust L, Devlin B, Foster SJ et al. Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 2004;6:7-14.
20. Dahl JA, Duggal S, Coulston N et al. Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. Int J Dev Biol 2008;52:1033-1042.
21. Niemeyer P, Kornacker M, Mehlhorn A et al. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Tissue Eng 2007; 13:111-121.
22. Paredes B, Santana A, Arribas MI et al. Phenotypic differences during the osteogenic differentiation of single cell-derived clones isolated from human lipoaspirates. J Tissue Eng Regen Med 2011;5:589-599.
23. Rajashekhar G, Traktuev DO, Roell WC et al. IFATS collection: Adipose stromal cell differentiation is reduced by endothelial cell contact and paracrine communication: Role of canonical Wnt signaling. STEM CELLS 2008;26: 2674-2681.
24. Meury T, Verrier S, Alini M. Human endothelial cells inhibit BMSC differentiation into mature osteoblasts in vitro by interfering with osterix expression. J Cell Biochem 2006;98: 992-1006.
25. Crisan M, Yap S, Casteilla L et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3: 301-313.
26. Crisan M, Chen CW, CorselliMet al. Perivascular multipotent progenitor cells in human organs. Ann N Y Acad Sci 2009;1176:118-123.
27. Crisan M, Corselli M, ChenCWet al. Multilineage stem cells in the adult: A perivascular legacy? Organogenesis 2011;7:101-104.
28. Crisan M, Deasy B, GavinaMet al. Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: Myoendothelial cells and pericytes. Methods Cell Biol 2008;86:295-309.
29. Corselli M, Chen CW, CrisanMet al. Perivascular ancestors of adult multipotent stem cells. Arterioscler Thromb Vasc Biol 2010;30: 1104-1109.
30. Corselli M, Chen CW, Sun B et al. The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev 2012;21:1299-1308.
31. Zhang X, Péault B, ChenWet al. The Nell- 1 growth factor stimulates bone formation by purified human perivascular cells. Tissue Eng Part A 2011;17:2497-2509.
32. James AW, Zara JN, Zhang X et al. Perivascular stem cells: A prospectively purified mesenchymal stem cell population for bone tissue engineering. STEM CELLS TRANSLATIONAL MEDICINE 2012;1:510-519.
33. AskarinamA, JamesAW,Zara JN et al. Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with NELL-1 protein. Tissue Eng Part A 2013;19:1386-1397.
34. James A, Zara J et al. STEM CELLS TRANSLATIONAL MEDICINE 2012;1:673-684.
35. Li W, Lee M, Whang J et al. Delivery of lyophilized Nell-1 in a rat spinal fusion model. Tissue Eng Part A 2010;16:2861-2870.
36. Grauer JN, Patel TC, Erulkar JS et al. 2000 Young Investigator Research Award winner: Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion. Spine 2001; 26:127-133.
37. ParfittAM,DreznerMK, GlorieuxFHet al. Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 1987;2:595-610.
38. Odgaard A, Linde F. The underestimation of Young's modulus in compressive testing of cancellous bone specimens. J Biomech 1991; 24:691-698.
39. Keaveny TM, Pinilla TP, Crawford RP et al. Systematic and random errors in compression testing of trabecular bone. J Orthop Res 1997; 15:101-110.
40. Zhu M, Keller TS, Spengler DM. Effects of specimen load-bearing and free surface layers on the compressive mechanical properties of cellular materials. J Biomech 1994;27:57-66.
41. Lu SS, Zhang X, Soo C et al. The osteoinductive properties of Nell-1 in a rat spinal fusion model. Spine J 2007;7:50-60.
42. Kuo CS, Hu HT, Lin RM et al. Biomechanical analysis of the lumbar spine on facet joint force and intradiscal pressure:Afinite element study. BMC Musculoskelet Disord 2010;11: 151.
43. Lee M, Li W, Siu RK et al. Biomimetic apatite-coated alginate/chitosan microparticles as osteogenic protein carriers. Biomaterials 2009;30:6094-6101.
44. Scott MA, Levi B, Askarinam A et al. Brief review of models of ectopic bone formation. Stem Cells Dev 2012;21:655-667.
45. Spicer PP, Kretlow JD, Young S et al. Evaluation of bone regeneration using the rat critical size calvarial defect. Nat Protoc 2012;7: 1918-1929.
46. Koerner JD, Yalamanchili P, Munoz W et al. The effects of local insulin application to lumbar spinal fusions in a rat model. Spine J 2013;13:22-31.
47. Yuan W, James AW, Asatrian G et al. NELL-1 based demineralized bone graft promotes rat spine fusion as compared to commercially available BMP-2 product. J Orthop Sci 2013;18:646-657.
48. Gupta MC, Theerajunyaporn T, Maitra S et al. Efficacy of mesenchymal stem cell enriched grafts in an ovine posterolateral lumbar spinemodel. Spine 2007;32:720-726; discussion 727.
49. Minamide A, Yoshida M, Kawakami M et al. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion. Spine 2005;30:1134-1138.
50. Cui Q,Ming Xiao Z, Balian G et al. Comparison of lumbar spine fusion using mixed and cloned marrow cells. Spine 2001;26:2305-2310.
51. Lopez MJ, McIntosh KR, SpencerNDet al. Acceleration of spinal fusion using syngeneic and allogeneic adult adipose derived stem cells in a rat model. J Orthop Res 2009;27:366-373.
52. Miyazaki M, Zuk PA, Zou J et al. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model. Spine 2008;33:863-869.
53. Bruder SP, Jaiswal N, Ricalton NS et al. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res 1998;;355(suppl):S247-S256.
54. Muschler GF, Matsukura Y, Nitto H et al. Selective retention of bone marrow-derived cells to enhance spinal fusion. Clin Orthop Relat Res 2005;432:242-251.
55. McLain RF, Fleming JE, Boehm CA et al. Aspiration of osteoprogenitor cells for augmenting spinal fusion: Comparison of progenitor cell concentrations from the vertebral body and iliac crest. J Bone Joint Surg Am 2005;87:2655-2661.
56. WangT, Dang G, GuoZ et al. Evaluation of autologous bone marrow mesenchymal stem cell-calcium phosphate ceramic composite for lumbar fusion in rhesus monkey interbody fusion model. Tissue Eng 2005;11:1159-1167.
57. Kai T, Shao-qing G, Geng-ting D. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion. Spine 2003;28: 1653-1658.
58. Nakajima T, Iizuka H, Tsutsumi S et al. Evaluation of posterolateral spinal fusion using mesenchymal stem cells: Differences with or without osteogenic differentiation. Spine 2007; 32:2432-2436.
59. Zeng Q, Li X, Beck G et al. Growth and differentiation factor-5 (GDF-5) stimulates osteogenic differentiation and increases vascular endothelial growth factor (VEGF) levels in fatderived stromal cells in vitro. Bone 2007;40: 374-381.
60. Hsu WK, Wang JC, Liu NQ et al. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model. J Bone Joint Surg Am 2008;90:1043- 1052.
61. Chen CW, Corselli M, Peault B et al. Human blood-vessel-derived stem cells for tissue repair and regeneration. J Biomed Biotechnol 2012;2012:597439.
62. Feng J, Mantesso A, Sharpe PT. Perivascular cells as mesenchymal stem cells. Expert Opin Biol Ther 2010;10:1441-1451.
63. JamesAW,Zara JN, CorselliMet al. Use of human perivascular stem cells for bone regeneration. J Vis Exp 2012;63:e2952.
64. Tottey S, Corselli M, Jeffries EM et al. Extracellular matrix degradation products and low-oxygen conditions enhance the regenerative potential of perivascular stem cells. Tissue Eng Part A 2011;17:37-44.
65. Udani VM, Santarelli JG, Yung YC et al. Hematopoietic stem cells give rise to perivascular endothelial-like cells during brain tumor angiogenesis. Stem Cells Dev 2005;14:478-486.
66. Chen CW, Montelatici E, Crisan M et al. Perivascular multi-lineage progenitor cells in human organs: Regenerative units, cytokine sources or both? Cytokine Growth Factor Rev 2009;20:429-434.
67. Ozaki Y, NishimuraM, Sekiya K et al. Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev 2007;16:119-129.
68. Uchida K, Urabe K, Naruse K et al. Comparison of the cytokine-induced migratory response between primary and subcultured populations of rat mesenchymal bone marrow cells. J Orthop Sci 2007;12:484-492.
69. Ponte AL, Marais E, Gallay N et al. The in vitro migration capacity ofhumanbone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. STEM CELLS 2007;25:1737-1745.
70. Oshima Y, Watanabe N, Matsuda K et al. Behavior of transplanted bone marrow-derived GFP mesenchymal cells in osteochondral defect as a simulation of autologous transplantation. J Histochem Cytochem 2005;53:207-216.
71. Oshima Y, Watanabe N, Matsuda K et al. Fate of transplanted bone-marrow-derived mesenchymal cells during osteochondral repair using transgenic rats to simulate autologous transplantation. Osteoarthritis Cartilage 2004; 12:811-817.
72. Murray IR, West CC, HardyWR et al. Natural history of mesenchymal stem cells, from vessel walls to culture vessels. Cell Mol Life Sci 2014;71:1353-1374.
73. Tang W, Zeve D, Suh JM et al. White fat progenitor cells reside in the adipose vasculature. Science 2008;322:583-586.
74. Dellavalle A, Maroli G, Covarello D et al. Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. Nat Commun 2011;2:499.
75. Krautler NJ, Kana V, Kranich J et al. Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell 2012;150:194- 206.
76. Olson LE, Soriano P. PDGFRb signaling regulates mural cell plasticity and inhibits fat development. Dev Cell 2011;20:815-826.
77. Henderson NC, Arnold TD, Katamura Y et al. Targeting of av integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med 2013;19:1617- 1624.
78. Shamsul BS, Tan KK, Chen HC et al. Posterolateral spinal fusion with ostegenesis induced BMSC seeded TCP/HA in a sheep model. Tissue Cell 2014;46:152-158.
79. Oedayrajsingh-Varma MJ, van Ham SM, Knippenberg M et al. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissueharvesting procedure. Cytotherapy 2006;8: 166-177.
80. Jurgens WJ, Oedayrajsingh-Varma MJ, Helder MN et al. Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: Implications for cell-based therapies. Cell Tissue Res 2008;332:415-426.